Sort
53,477 grants matching “addiction”
Communicating about Nicotine and Differential Risks of Tobacco Products in Priority Populations
$776,274Lyudmila Popova · Georgia State University · R01 · FY2025 · CA
Rapid response human testing of smokeless tobacco products
$776,248Pamela I Clark · Univ Of Maryland, College Park · R01 · FY2012 · DA
Project 4: Using a prospective cohort survey to test population-level predictions generated by Projects 1-3
$776,210Joanna E Cohen · Virginia Commonwealth University · U54 · FY2022 · DA
A randomized double-blind, placebo-controlled phase 2 clinical trial of intravenous citrulline for vaso-occlusive crisis in sickle cell disease
$776,011Suvankar Majumdar · Children'S Research Institute · R61 · FY2024 · HL
Probing the Structure of the Synapse Using Superresolution Light Microscopy
$775,833Gina G Turrigiano · Brandeis University · DP1 · FY2007 · OD
Translating CBD Treatment for Heroin Addiction
$775,802Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DA
Delaware Valley Node of the Clinical Trials Network
$775,738George E Woody · University Of Pennsylvania · U10 · FY2012 · DA
Career Enhancement Core
$775,688Stephanie S O'Malley · Yale University · U54 · FY2025 · DA
A Wirelss Wearable System to Measure Adherence to Mind-Body Study Protocols
$775,674Paul L Gibson · Advanced Medical Electronics Corporation · R44 · FY2007 · AT
Mid Southern Primary Care Networks Node
$775,477Li-Tzy T Wu · Duke University · UG1 · FY2016 · DA
CAREER: Instrumental divergence and goal-directed choice
$775,331Mimi Liljeholm · University Of California-Irvine · · FY2017 · SBE
Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder
$775,091Risa B Weisberg · Behavr, Llc · R44 · FY2023 · DA
Harnessing Knowledge of Gene Function in Brain Tissue for Discovering Biology Underlying Heroin Addiction
$774,951Eric O Johnson · Research Triangle Institute · R01 · FY2021 · DA
Development and Validation of a Mouse Model of Intervertebral Disc Degeneration-Induced Low Back Pain to Facilitate Non-Addictive Analgesic Discovery
$774,930Laura S Stone · University Of Minnesota · R61 · FY2024 · NS
Clinical Trials Network: The Texas Node
$774,920Madhukar H Trivedi · Ut Southwestern Medical Center · U10 · FY2011 · DA
Optical Tools to Assess the Role of Cardiac Function in the Development of Congenital Heart Defects
$774,900Michael W. Jenkins · Case Western Reserve University · R01 · FY2022 · HL
An Innovative Intervention for OUD Treatment
$774,845Eric C Strain · Johns Hopkins University · R01 · FY2020 · DA
Implementation to motivate physician response to opioid dependence in HIV setting
$774,599Peter D. Friedmann · Rhode Island Hospital · R01 · FY2014 · DA
HIV, Buprenorphine, and the Criminal Justice System
$774,518Frederick Lewis Altice · Yale University · R01 · FY2011 · DA
Development of MRGPRX1 positive allosteric modulators as non-addictive therapies for neuropathic pain
$774,484Takashi Tsukamoto · Johns Hopkins University · UH3 · FY2023 · NS
Neurobehavioral Determinants of Health Risk Behaviors: From Adolescence to Young Adulthood
$774,184Jungmeen Kim · Virginia Polytechnic Inst And St Univ · R01 · FY2020 · DA
Small, Noncoding RNAs
$774,038Gisela Storz · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Establishing Oprm1 exon 7-associated variants as novel therapeutic targets for mitigating adverse effects of clinically used mu opioids without altering analgesia in pain management
$773,957Ying-Xian Pan · Rutgers Biomedical And Health Sciences · R01 · FY2025 · DA
Targeting System Xc- for the Treatment of Addiction
$773,859David A Baker · Marquette University · R01 · FY2009 · DA
Optimizing a Just-in-Time Adaptive Intervention to Increase Uptake of Chemsex Harm Reduction Services in MSM: A Micro-randomized Trial
$773,845Roman Shrestha · University Of Connecticut Storrs · R01 · FY2024 · DA